SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-23-010898
Filing Date
2023-02-14
Accepted
2023-02-13 17:47:11
Documents
1
Group Members
VIVO OPPORTUNITY, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13G ea173391-13ga3vivo7_verona.htm SC 13G/A 92175
  Complete submission text file 0001213900-23-010898.txt   93647
Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 (650) 688-0822
VIVO VENTURES VII, LLC (Filed by) CIK: 0001565020 (see all company filings)

IRS No.: 274484686 | State of Incorp.: CA
Type: SC 13G/A

Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Subject) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89843 | Film No.: 23620427
SIC: 2834 Pharmaceutical Preparations